Skip to main content
. 2022 Jul 5;32(7):303–313. doi: 10.2188/jea.JE20200399

Table 2. Characteristics of study participants according to non-fasting triglyceride category at the baseline survey.

  Baseline triglyceride level
≤59 mg/dL 60–89 mg/dL 90–119 mg/dL 120–149 mg/dL 150–179 mg/dL 180–209 mg/dL ≥210 mg/dL
Total (n = 6,831)
Number of participants, n 878 1,641 1,427 948 631 423 883
Age, years 48.2 (13.7) 51.2 (14.0) 53.2 (13.7) 53.5 (13.1) 53.7 (13.1) 53.9 (13.8) 53.1 (12.8)
Body mass index, kg/m2 21.1 (2.7) 21.9 (2.9) 22.7 (3.1) 23.4 (3.2) 24.0 (3.1) 24.1 (2.9) 24.6 (2.99
Non-fasting blood glucose, mg/dL 94.8 (19.8) 99.1 (23.4) 102.1 (25.7) 105.5 (40.7) 103.8 (29.0) 109.9 (42.3) 109.5 (41.8)
Hemoglobin A1c, % 5.1 (0.5) 5.2 (0.6) 5.2 (0.6) 5.3 (0.8) 5.4 (0.8) 5.5 (0.9) 5.5 (1.0)
Diabetes, n (%) 18 (2.1%) 35 (2.1%) 50 (3.5%) 59 (6.2%) 33 (5.2%) 34 (8.0%) 81 (9.2%)
Systolic blood pressure, mm Hg 127.4 (20.4) 131.7 (20.1) 134.9 (20.0) 138.5 (21.7) 137.7 (19.6) 138.5 (20.0) 140.1 (19.0)
Diastolic blood pressure, mm Hg 76.8 (11.1) 79.2 (11.6) 81.0 (11.4) 82.3 (12.5) 83.6 (10.7) 82.8 (12.2) 84.9 (11.7)
Hypertension, n (%) 245 (27.9%) 598 (36.4%) 649 (45.5%) 493 (52.0%) 320 (50.7%) 223 (52.7%) 505 (57.2%)
Total cholesterol, mg/dL 180.9 (30.8) 192.9 (33.0) 199.0 (34.8) 209.8 (34.1) 213.2 (35.1) 216.8 (38.4) 223.6 (40.5)
HDL cholesterol, mg/dL 64.7 (14.5) 60.4 (14.7) 55.1 (13.5) 51.9 (12.7) 48.1 (12.4) 46.4 (12.0) 41.7 (11.4)
Triglycerides, mg/dL 50 [44–55] 75 [68–82] 104 [97–111] 133 [126–140] 163 [156–170] 193 [186–201] 264 [231–336]
Current smoker, n (%) 196 (22.3%) 383 (23.3%) 411 (28.8%) 274 (28.9%) 213 (33.8%) 151 (35.7%) 328 (37.2%)
Current drinker, n (%) 207 (23.6%) 409 (24.9%) 405 (28.4%) 269 (28.4%) 179 (28.4%) 147 (34.8%) 338 (38.3%)

HDL, high-density lipoprotein.

Data are presented as mean (standard deviation), median [interquartile range] or as a number (%).